-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: keymaster@town.hall.org Originator-Key-Asymmetric: MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ== MIC-Info: RSA-MD5,RSA, r9vG7R9AEvdTRwWADEbcjhrYXhXx+tajtOJMqTWSFOeI/+zJBXHC5sLaQTgHmjBt tuLq60pWAr1KPsD8HLiYZA== 0000318154-95-000026.txt : 19950906 0000318154-95-000026.hdr.sgml : 19950906 ACCESSION NUMBER: 0000318154-95-000026 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 19950831 ITEM INFORMATION: Other events FILED AS OF DATE: 19950905 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 95570085 BUSINESS ADDRESS: STREET 1: 1840 DEHAVILLAND DR CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1789 BUSINESS PHONE: 0854471000 MAIL ADDRESS: STREET 1: 1840 DEHAVILLAND DR. STREET 2: MAIL STOP 10-1-B-512 CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1789 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 8-K 1 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K Current Report Pursuant to Section 13 or 15(d) of The Securities Act of 1934 Date of Report (Date of earliest event reported) August 31, 1995 --------------- Amgen Inc. ------------------------------------------------------------ (Exact name of registrant as specified in its charter) Delaware 0-12477 95-3540776 ------------------------------------------------------------ (State or other (Commission (I.R.S. Employer jurisdiction File Number) Identification No.) of incorporation) 1840 Dehavilland Drive, Thousand Oaks, California 91320-1789 ------------------------------------------------------------ (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code (805) 447-1000 -------------- ------------------------------------------------------------- (Former name or former address, if changed since last report) Item 5. OTHER EVENTS ------------ Amgen Inc. (the "Company") and one of its licensees, Ortho Pharmaceutical Corporation, a subsidiary of Johnson & Johnson ("Johnson & Johnson"), are parties to an arbitration proceeding described in the Company's Form 10-K for the year ended December 31, 1994 and the Company's Form 10-Q for the period ended June 30, 1995. On August 31, 1995, the Company filed a demand in the arbitration seeking: (1) termination of the product license agreement between the Company and Johnson & Johnson, (2) an accounting of Johnson & Johnson's spillover sales and (3) damages. The Company is unable to predict at this time the outcome of this demand or when it will be resolved. Signatures ---------- Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Amgen Inc. ----------------------------------- (Registrant) September 1, 1995 /s/ Robert S. Attiyeh ----------------- ----------------------------------- (Date) (Signature) Robert S. Attiyeh Senior Vice President Finance and Corporate Development, and Chief Financial Officer -----END PRIVACY-ENHANCED MESSAGE-----